The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers. The ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Discover the power of hydrogel: researchers at Penn State mimic tissue behaviors using special hydrogels for potential ...

A research team from the Eye & ENT Hospital of Fudan University, China, has developed a novel biocompatible nanoadhesive for ...

Exosomes, naturally occurring extracellular vesicles, have garnered increasing interest in the field of cosmetics and skincare due to their regenerative pr | Drug Discovery And Development ...

Calendula cream accelerates wound healing and enhances skin hydration due to its anti-inflammatory antimicrobial and ...

The Australian market has recently seen mixed performance, with the ASX200 closing slightly down by 0.11% at 8,511 points. Despite some sectors facing declines, IT and Staples have shown resilience, ...

The global hyperbaric oxygen therapy (HBOT) devices market, valued at USD 3.47 billion in 2023, is poised for significant growth, reaching USD 6.86 billion by 2033 at a CAGR of 7.0%. This surge is ...